Houston, TX10 Active Studies

Interstitial Lung Disease Clinical Trials in Houston, TX

Find 10 actively recruiting interstitial lung disease clinical trials in Houston, TX. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
14,728
Enrolling

Recruiting Interstitial Lung Disease Studies in Houston

About Interstitial Lung Disease Clinical Trials in Houston

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 10 interstitial lung disease clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 14,728 participants. Research is being sponsored by Boston Children's Hospital, University of California, Davis, The University of Texas Health Science Center, Houston and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Houston — FAQ

Are there interstitial lung disease clinical trials in Houston?

Yes, there are 10 interstitial lung disease clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 10 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated October 19, 2026 from ClinicalTrials.gov